Effects of acute and chronic attenuation of postprandial hyperglycemia on postglucose-load endothelial function in insulin resistant individuals: is stimulation of first phase insulin secretion beneficial for the endothelial function?
暂无分享,去创建一个
L. Køber | C. Rask-Madsen | C. Torp-Pedersen | N. Ihlemann | O. Svendsen | A. Major-Pedersen | B. Kveiborg | B. Christiansen | H. Domínguez | T. Hermann | D. Nielsen | A. Major‐Pedersen | D. B. Nielsen | Buris Christiansen | Britt Kveiborg | L. Køber | Lars Køber
[1] T. Hansen,et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. , 2007, Journal of the American College of Cardiology.
[2] Richard Kahn,et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.
[3] J Herlitz,et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. , 2005, European heart journal.
[4] N. Tajima,et al. Role of early insulin secretion in postglucose‐loading hyperglycaemia and postfat‐loading hyperlipidaemia: comparing nateglinide and glibenclamide for acute effects on insulin secretion in OLETF rats , 2004, Diabetes, obesity & metabolism.
[5] L. Køber,et al. Hyperinsulinaemia is associated with increased long-term mortality following acute myocardial infarction in non-diabetic patients. , 2004, European heart journal.
[6] M. Shimabukuro,et al. A single dose of nateglinide improves post‐challenge glucose metabolism and endothelial dysfunction in Type 2 diabetic patients , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[7] M. Itoh,et al. The antidiabetic agent, gliclazide, reduces high insulin–enhanced neutrophil‐transendothelial migration through direct effects on the endothelium , 2004, Diabetes/metabolism research and reviews.
[8] C. Kahn,et al. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. , 2003, The Journal of clinical investigation.
[9] J. Tuomilehto,et al. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? , 2003, Diabetes care.
[10] A. Ceriello,et al. Evidence for an Independent and Cumulative Effect of Postprandial Hypertriglyceridemia and Hyperglycemia on Endothelial Dysfunction and Oxidative Stress Generation: Effects of Short- and Long-Term Simvastatin Treatment , 2002, Circulation.
[11] B. Waitzfelder,et al. The American Diabetes Association and World Health Organization classifications for diabetes: their impact on diabetes prevalence and total and cardiovascular disease mortality in elderly Japanese-American men. , 2002, Diabetes care.
[12] M. Weston. Comparison of Doppler ultrasound, magnetic resonance angiographic techniques and catheter angiography in evaluation of carotid stenosis. , 2002, Clinical radiology.
[13] V R Newey,et al. Online artery diameter measurement in ultrasound images using artificial neural networks. , 2002, Ultrasound in medicine & biology.
[14] E. Benjamin,et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. , 2002, Journal of the American College of Cardiology.
[15] A. Dornhorst. Insulinotropic meglitinide analogues , 2001, The Lancet.
[16] H. Keen,et al. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes , 2001, Diabetologia.
[17] A. Dart,et al. Diurnal Variation in Endothelium-Dependent Vasodilatation Is Not Apparent in Coronary Artery Disease , 2001, Circulation.
[18] E. Feskens,et al. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. , 2001, Archives of internal medicine.
[19] L. Lind,et al. Evaluation of endothelium-dependent vasodilation in the human peripheral circulation. , 2000, Clinical Physiology.
[20] A. Zeiher,et al. Atherosclerosis-associated endothelial dysfunction , 2000, Zeitschrift für Kardiologie.
[21] J. Shaw,et al. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality , 1999, Diabetologia.
[22] F. Ohsuzu,et al. Morning attenuation of endothelium‐dependent, flow‐mediated dilation in healthy young men: Possible connection to morning peak of cardiac events? , 1999, Clinical cardiology.
[23] A Sekikawa,et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. , 1999, Diabetes care.
[24] J. Sowers,et al. Insulin potentiates platelet-derived growth factor action in vascular smooth muscle cells. , 1998, Endocrinology.
[25] J. A. Hunt,et al. Variation of Postprandial Plasma Glucose, Palatability, and Symptoms Associated With a Standardized Mixed Test Meal Versus 75 g Oral Glucose , 1998, Diabetes Care.
[26] J. K. Lloyd,et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis , 1992, The Lancet.